Influence of immunological markers of cardiovascular risk on atherosclerosis early development in patients with rheumatoid arthritis

Authors

  • Ivan Fushtey State Institution “Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine” Vintera blvd., 20, Zaporizhzhia, Ukraine, 69096, Ukraine https://orcid.org/0000-0001-5629-5264
  • Svitlana Podsevahina State Institution “Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine” Vintera blvd., 20, Zaporizhzhia, Ukraine, 69096, Ukraine https://orcid.org/0000-0001-7851-1706
  • Olexandr Palamarchuk State Institution “Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine” Vintera blvd., 20, Zaporizhzhia, Ukraine, 69096, Ukraine https://orcid.org/0000-0003-3159-3649
  • Olga Tkachenko State Institution “Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine” Vintera blvd., 20, Zaporizhzhia, Ukraine, 69096, Ukraine https://orcid.org/0000-0003-1454-4837

DOI:

https://doi.org/10.15587/2519-4798.2019.161850

Keywords:

rheumatoid arthritis, course of the disease, cardiovascular risk, cytokines, C-reactive protein, atherosclerosis

Abstract

Aim of the study. To investigate the peculiarities of immunological markers of systemic inflammation in patients with rheumatoid arthritis (RA) depending on the clinical-immunological variant of the course of RA and on the duration of the disease.

Materials and methods. We examined 82 patients with RA, aged (37.6±5,1) years. The history of the disease was less than 3 years in 47.5 % of patients (n=39) and in 52.5 % of patients (n=43) – it was more than 3 years. In 48 (58.5 %) patients a seropositive variant of RA was observed and 34 (41.5 %) patients were with seronegative variant of the disease. All patients underwent a complex clinical, laboratory and immunological examination. RA activity was assessed using the DAS 28 index; immune-enzyme assay method was used to assess the level of rheumatoid factor (RF), antibodies to cyclic citrulinated peptide (ACCP), C-reactive protein (CRP), proinflammatory cytokines (tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and IL-6).

Results. The levels of pro-inflammatory cytokines in RA showed a statistically significant increase in their concentration in all groups of examined patients compared with the control one. The highest levels of TNF-α (p=0.046) and IL-1β (p=0.025) were in the group of patients with the seronegative variant of RA lasting less than 3 years; the highest concentration of IL-6 (p=0.018) was determined in patients with a long course of seropositive RA. Correlation analysis allowed determining the association of hyperproduction of TNF-α, IL-1β and IL-6 with the duration of RA and disease activity. In all groups of patients with RA an increase in the serum CRP concentration was detected. It was more expressed in patients with a seropositive variant of RA with a disease duration of more than 3 years. In addition, correlation links between CRP and IL-6, IL-1β, TNF-α have been established. The direct correlation between the level of CRP and the DAS28 index (p<0.0001), RF concentration, ACCP (p=0.05) was also revealed.

Conclusions. A study in the serum of mediators of immune inflammation in patients with different clinical and immunological variants and duration of RA revealed differences in their content. In patients with anamnesis of RA less than 3 years, a predominant increase in TNF-α and IL-1β was detected in case of a seronegative disease type. In patients with a disease duration of seropositive RA for more than 3 years, the content of IL-6 was increased largely, compared with rates in patients with a similar duration of the seronegative disease. In patients with a RA seropositive duration of more than 3 years, the CRP content was 1.3 times (p=0.05) higher than in the group of patients with a history of the disease less than 3 years and 1,6 times (p=0.001) higher than in patients with similar duration of seronegative RA

Author Biographies

Ivan Fushtey, State Institution “Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine” Vintera blvd., 20, Zaporizhzhia, Ukraine, 69096

MD, Professor

Department of Therapy, Clinical Pharmacology and Endocrinology

Svitlana Podsevahina, State Institution “Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine” Vintera blvd., 20, Zaporizhzhia, Ukraine, 69096

PhD, Associate Professor

Department of Therapy, Clinical Pharmacology and Endocrinology

Olexandr Palamarchuk, State Institution “Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine” Vintera blvd., 20, Zaporizhzhia, Ukraine, 69096

PhD, Associate Professor

Department of Therapy, Clinical Pharmacology and Endocrinology

Olga Tkachenko, State Institution “Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine” Vintera blvd., 20, Zaporizhzhia, Ukraine, 69096

MD, Associate Professor

Department of Therapy, Clinical Pharmacology and Endocrinology

References

  1. Berezin, A. E. (2013). Revmatoidnyy artrit i kardiovaskulyarnyy risk [Rheumatoid arthritis and cardiovascular risk]. Ukrainian Rheumatology Journal, 2, 34–45.
  2. Kremers, H. M., Crowson, C. S., Therneau, T. M., Roger, V. L., Gabriel, S. E. (2008). High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: A population-based cohort study. Arthritis & Rheumatism, 58 (8), 2268–2274. doi: http://doi.org/10.1002/art.23650
  3. Wolfe, F., Michaud, K. (2008). The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: A cohort and nested case-control analysis. Arthritis & Rheumatism, 58 (9), 2612–2621. doi: http://doi.org/10.1002/art.23811
  4. Sandoo, A., Hodson, J., Douglas, K. M., Smith, J. P., Kitas, G. D. (2013). The association between functional and morphological assessments of endothelial function in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Research & Therapy, 15 (5), R107. doi: http://doi.org/10.1186/ar4287
  5. Sandoo, A., Veldhuijzen van Zanten, J. J. C. S., Metsios, G. S., Carroll, D., Kitas, G. D. (2011). Vascular function and morphology in rheumatoid arthritis: a systematic review. Rheumatology, 50 (11), 2125–2139. doi: http://doi.org/10.1093/rheumatology/ker275
  6. Aviña-Zubieta, J. A., Choi, H. K., Sadatsafavi, M., Etminan, M., Esdaile, J. M., Lacaille, D. (2008). Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies. Arthritis & Rheumatism, 59 (12), 1690–1697. doi: http://doi.org/10.1002/art.24092
  7. Amaya-Amaya, J., Montoya-Sánchez, L., Rojas-Villarraga, A. (2014). Cardiovascular Involvement in Autoimmune Diseases. BioMed Research International, 2014, 1–31. doi: http://doi.org/10.1155/2014/367359
  8. Krichevskaya, O. A., Klyukvina, N. G., Alexandrova, E. N., Alekperov, R. T., Nasonov, E. L. (2005). Tumor necrosis factor a and its soluble receptors in rheumatic diseases: clinical and pathogenetic significance. Rheumatology Science and Practice, 2, 43–46. doi: http://doi.org/10.14412/1995-4484-2005-1524
  9. Popkova, T. V., Novikov, D. S., Nasonov, E. L. (2011). Interleykin 6 i serdechno-sosudistaya patologiya pri revmatoidnom artrite. Rheumatology Science and Practice, 4, 64–72. doi: http://doi.org/10.14412/1995-4484-2011-63
  10. Ozbalkan, Z., Efe, C., Cesur, M., Ertek, S., Nasiroglu, N., Berneis, K., Rizzo, M. (2010). An update on the relationships between rheumatoid arthritis and atherosclerosis. Atherosclerosis, 212 (2), 377–382. doi: http://doi.org/10.1016/j.atherosclerosis.2010.03.035
  11. Vizir, V. A., Berezin, A. E. (2010). Immunopatologiya ateroskleroza. Znacheniye biologicheskikh markerov v otsenke kardiovaskulyarnogo riska [Immunopathology of atherosclerosis. The value of biological markers in assessing cardiovascular risk]. Ukrainian medical journal, 2, 76–83.
  12. Popkova, T. V., Novikova, D. S., Nasonov, E. L. (2016). Ingibirovaniye interleykina-6 I serdechno-sosudistaya patologiya u bol'nykhr evmatoidnym artritom [Interleukin-6 inhibition and cardiovascular pathology in patients with rheumatoid arthritis]. Therapeutic archive, 5, 93–101.
  13. Solomon, D. H., Reed, G. W., Kremer, J. M., Curtis, J. R., Farkouh, M. E., Harrold, L. R. et. al. (2015). Disease Activity in Rheumatoid Arthritis and the Risk of Cardiovascular Events. Arthritis & Rheumatology, 67 (6), 1449–1455. doi: http://doi.org/10.1002/art.39098
  14. González-Gay, M. A., González-Juanatey, C. (2012). Inflammation, endothelial function and atherosclerosis in rheumatoid arthritis. Arthritis Research & Therapy, 14 (4), 122. doi: http://doi.org/10.1186/ar3891
  15. Arabidze, G. G. (2013). Klinicheskaya immunologiya ateroskleroza – ot teorii k praktike [Clinical immunology of atherosclerosis – from theory to practice]. Atherosclerosis and dyslipidemia, 1, 4–19.
  16. Gómez-Guerrero, C., Mallavia, B., Egido, J. (2011). Targeting Inflammation in Cardiovascular Diseases. Still a Neglected field? Cardiovascular Therapeutics, 30 (4), 189–197. doi: http://doi.org/10.1111/j.1755-5922.2011.00274.x
  17. Krougly, L. B. K., Fomicheva, O. A. F., Karpov, Y. A. K., Popkova, T. V. P., Novikova, D. S. N., Nasonov, E. L. N. (2016). Cardiovascular Complications of Rheumatoid Arthritis: Prevalence and Pathogenesis. Kardiologiia, 6, 89–95. doi: http://doi.org/10.18565/cardio.2016.6.89-95
  18. Novikov, A. A., Aleksandrova, E. N., Diatroptova, M. A., Nasonov, E. L. (2010). Role of cytokines in the pathogenesis of rheumatoid arthritis. Rheumatology Science and Practice, 48 (2), 71–82. doi: http://doi.org/10.14412/1995-4484-2010-1420
  19. Poredoš, P., Kaja Ježovnik, M. (2015). Markers of preclinical atherosclerosis and their clinical relevance. Vasa, 44 (4), 247–256. doi: http://doi.org/10.1024/0301-1526/a000439
  20. Ridker, P. M. (2007). C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk. Journal of the American College of Cardiology, 49 (21), 2129–2138. doi: http://doi.org/10.1016/j.jacc.2007.02.052

Downloads

Published

2019-04-02

How to Cite

Fushtey, I., Podsevahina, S., Palamarchuk, O., & Tkachenko, O. (2019). Influence of immunological markers of cardiovascular risk on atherosclerosis early development in patients with rheumatoid arthritis. ScienceRise: Medical Science, (2 (29), 4–9. https://doi.org/10.15587/2519-4798.2019.161850

Issue

No. 2 (29) (2019)

Section

Medical Science

License

Copyright (c) 2019 Ivan Fushtey, Svitlana Podsevahina, Olexandr Palamarchuk, Olga Tkachenko

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.